[{"Assets_0_Q2_USD":199865000.0,"CommonStockSharesOutstanding_0_Q2_shares":112462283.0,"EarningsPerShareBasic_1_Q2_USD":0.08,"EarningsPerShareBasic_2_Q2_USD":0.12,"EarningsPerShareDiluted_1_Q2_USD":0.07,"EarningsPerShareDiluted_2_Q2_USD":0.11,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":24123000.0,"NetIncomeLoss_1_Q2_USD":8069000.0,"NetIncomeLoss_2_Q2_USD":12396000.0,"StockholdersEquity_0_Q2_USD":147270000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":117285865.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":115856317.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":106805162.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":106254433.0,"Ticker":"MDXG","CIK":"1376339","name":"MIMEDX GROUP, INC.","OfficialName":"MiMedx Group Inc Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"515730569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170731"}]